EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immune checkpoint inhibitor-associated acute interstitial nephritis: Pathogenesis and heterogeneity

Jiyang Jiang, Yuhan Zhou, Yao Yao, Liang Weng, Hui Wang iD

Cytojournal · 08.08.2026 · 23 · 50

DOI: 10.25259/cytojournal_68_2026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cytojournal, online erschienen am 08.08.2026. Verfasst von Jiyang Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing, China. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitor (ICI)-associated acute kidney injury is a significant complication of cancer immunotherapy, with acute interstitial nephritis (AIN) being the most common pathological type. This review systematically elaborates on the core pathogenesis, spectrum of pathological heterogeneity, and the distinct immunological underpinnings of ICI-associated AIN (ICI-AIN). The typical mechanism of ICI-AIN involves abnormal activation of the adaptive immune system, activating resident autoreactive CD8 + tissue-resident memory T cells. This triggers an interferon-gamma-driven inflammatory cascade, which subsequently recruits and activates myeloid cells, establishing a self-amplifying immune injury network. This type of mechanism can sometimes also form a tertiary lymphoid structure. Further research has unveiled a highly heterogeneous immunopathological spectrum of ICI-AIN, encompassing distinct subtypes often accompanied by features such as a dominant neutrophil infiltration and granulomatous interstitial nephritis. These subtypes correspond to differential immunopathogenic pathways and are closely associated with responses to glucocorticoid therapy and long-term renal outcomes. Future directions necessitate the integration of spatial multi-omics technologies and clinical studies to deeply dissect the immune cell interaction networks. Such efforts are critical to advancing the development of non-invasive diagnostics and targeted therapies, ultimately enabling precision clinical management of ICI-AIN.

Schlagwörter

Stichwörter der Autor:innen

Acute interstitial nephritisCD8+ tissue-resident memory T cellsImmune checkpoint inhibitorPathogenesisPathological heterogeneity

Autor:innen und Institutionen

  • Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.

ORCID-Profile: Hui Wang

Zitieren

APA

Jiang, J., Zhou, Y., Yao, Y., Weng, L., & Wang, H. (2026). Immune checkpoint inhibitor-associated acute interstitial nephritis: Pathogenesis and heterogeneity. Cytojournal, 23, 50. https://doi.org/10.25259/cytojournal_68_2026

Vancouver

Jiang J, Zhou Y, Yao Y, Weng L, Wang H. Immune checkpoint inhibitor-associated acute interstitial nephritis: Pathogenesis and heterogeneity. Cytojournal. 2026;23:50. doi:10.25259/cytojournal_68_2026

BibTeX
@article{Jiang2026,
  author = {Jiang, Jiyang and Zhou, Yuhan and Yao, Yao and Weng, Liang and Wang, Hui},
  title = {Immune checkpoint inhibitor-associated acute interstitial nephritis: Pathogenesis and heterogeneity},
  journal = {Cytojournal},
  year = {2026},
  volume = {23},
  pages = {50},
  doi = {10.25259/cytojournal_68_2026}
}
Kostenlos starten →